PharmaPendium for informed drug development decisions– Regulatory Pathways
Safety and efficacy continue to be the two major reasons why drugs fail in clinical trials. Join our free 45-...
The April content release includes the following updates:
FDA Approval Packages:
4 new drugs:
Aflibercept
Asparaginase Erwinia Chrysanthemi
Azilsartan Kamedoxomil; Chlorthalidone
Ingenol Mebutate...
The February content release includes the following updates :
FDA Approval Packages:
3 new drugs:
Bupivacaine
Ruxolitinib
Simvastatin; Sitagliptin Phosphate
1,061 new FDA Approval Documents
22,...
PharmaPendium announces its new PDF viewer:
No downloads or 3rd party software needed, the PharmaPendium viewer runs on the PharmaPendium platform
Significantly improved performance when searching,...
The December content release includes the following updates:
Year-To-Date EMA and FDA statistics:
133,152 new pages
6,809 new documents
228,462 new extracted PK data observations
102,532 new...
The October content release includes the following updates:
Year-To-Date EMA and FDA statistics:
100,612 new pages
5,254 new documents
196,291 new extracted PK data observations
66,030 new extracted...
The August content release includes the following updates:
FDA Approval Packages:
7 new drugs:
Abiraterone Acetate
Boceprevir
Gabapentin Enacarbil
Ibuprofen; Famotidine
Ipilimumab
Linagliptin...
The June content release includes the following updates:
FDA Approval Packages:
8 new drugs:
Azilsartan Medoxomil
Belimumab
Gadobutrol
Ioflupane I¹²³
Sodium Nitrite; Sodium...
The April content release includes the following updates:
FDA Approval Packages:
1 new drug: Aliskiren Hemifumarate; Amlodipine Besylate; Hydrochlorothiazide
808 new FDA approval documents
16,887...
The January content release includes the following updates:
FDA Approval Packages:
12 new drugs:
Aliskiren Hemifumarate; Amlodipine Besylate
Ceftaroline Fosamil
Dextromethorphan Hydrobromide;...
December PharmaPendium™ release contains the fully integrated Chemistry Structure Editor and Search Technology and the new PharmaPendium Published Toxicity Database
Chemistry Structure...
PharmaPendium is adding new content in the September content update, which includes the Pharmacokinetics Module.
FDA Approval Packages:
3 new drugs:
Dutasteride; Tamsulosin Hydrochloride...
Provides unprecedented access to detailed drug pharmacokinetics data and over 1,000,000 extracted exposure observations from the FDA and EMA documents on more than 2,100 drugs.
New York, NY –...
Safety Pharmacology Society
Boston, MA
Mon, 20/09/2010 - Thu, 23/09/2010
View Safety Pharmacology Society details
PharmaPendium is adding new content in the July content update.
FDA Approval Packages:
6 new drugs (Collagenase Clostridium Histolyticum, Dalfampridine, Ecallantide, Olanzapine Pamoate, Romidepsin...
Searchable FDA Advisory Committee documents are being added to PharmaPendium. In response to user’s demands, this expansion offers preclinical development and regulatory affairs even...
The December PharmaPendium content release brings the new totals for PharmaPendium to the following:
1,301,934 pages of FDA Approval documents (993,919 regular FDA & 308,015 FDA Classic...
The September release of PharmaPendium contains the following updates:
FDA Approval Packages:
5 New Drugs
Abobotulinumtoxina
Amlodipine; Hydrochlorothiazide; Valsartan
Besifloxacin Hydrochloride...
The July release of PharmaPendium contains the following updates:
FDA Classic Collection: No further updates.
FDA Approval Packages:
2 New Drugs
Benzyl Alcohol
Golimumab
689 New FDA Approval...
New York, NY – 2 June 2009 –– PharmaPendium, Elsevier’s online resource for authoritative preclinical, clinical and post-marketing drug information, has significantly...
In the 28th May 2009 release the following Content sources have been updated:
FDA Classic Collection:
757 New Drugs (list upon request)
5,771 New FDA Approval Documents
126,582 New pages of FDA...
Announcing the new PharmaPendium EMA database: the EMA European Public Assessment Report (EPAR) document database.
Now search EMA drug approval documents and FDA approval documents with a single...
PharmaPendium for informed drug development decisions– Regulatory Pathways...
Who uses PharmaPendium?
PharmaPendium is an invaluable resource for anyone involved in drug development. Discover who uses PharmaPendium
What is PharmaPendium?
PharmaPendium is a powerful online decision support and analysis tool. See how you can make more informed drug development decisions
Watch our video to find out how.
What others say about PharmaPendium.
Demo or Quote
Would you like to find out how Pharmapendium’s unique benefits support you and your colleagues? Contact us now
